Radiation Therapy for Spinal Metastases

Waqar Haque; Bin S. Teh

doi:10.1007/978-3-319-76252-4_20

Radiation Therapy for Spinal Metastases

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Up to 10% of all cancer patients develop metastatic disease in the bone. The purpose of the present report is to describe radiation therapy, including radionuclide treatment, conventional external beam radiation therapy (CEBRT), and stereotactic body radiation therapy (SBRT), for the management of spinal metastases. Radionuclide treatment can provide palliation in patients with painful skeletal metastases. CEBRT can be offered for palliation, treatment of cord compression, to prevent morbidity of bone metastases. Spinal SBRT can also be used for palliation or spinal cord compression and is typically recommended for us over CEBRT for radioresistant histologies.

Original language	English (US)
Title of host publication	Metastatic Spine Disease
Subtitle of host publication	A Guide to Diagnosis and Management
Publisher	Springer International Publishing
Pages	245-254
Number of pages	10
ISBN (Electronic)	9783319762524
ISBN (Print)	9783319762517
DOIs	https://doi.org/10.1007/978-3-319-76252-4_20
State	Published - Jan 1 2018

Keywords

Biological effective dose
Bone metastases
External beam radiation therapy
Radiation resistance
Radionuclide treatment
Stereotactic body radiation therapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-76252-4_20

Cite this

@inbook{12ffebf2358246e3ae5f149d7e68f9fd,

title = "Radiation Therapy for Spinal Metastases",

abstract = "Up to 10\% of all cancer patients develop metastatic disease in the bone. The purpose of the present report is to describe radiation therapy, including radionuclide treatment, conventional external beam radiation therapy (CEBRT), and stereotactic body radiation therapy (SBRT), for the management of spinal metastases. Radionuclide treatment can provide palliation in patients with painful skeletal metastases. CEBRT can be offered for palliation, treatment of cord compression, to prevent morbidity of bone metastases. Spinal SBRT can also be used for palliation or spinal cord compression and is typically recommended for us over CEBRT for radioresistant histologies.",

keywords = "Biological effective dose, Bone metastases, External beam radiation therapy, Radiation resistance, Radionuclide treatment, Stereotactic body radiation therapy",

author = "Waqar Haque and Teh, \{Bin S.\}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG, part of Springer Nature 2018.",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-3-319-76252-4\_20",

language = "English (US)",

isbn = "9783319762517",

pages = "245--254",

booktitle = "Metastatic Spine Disease",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Radiation Therapy for Spinal Metastases

AU - Haque, Waqar

AU - Teh, Bin S.

N1 - Publisher Copyright: © Springer International Publishing AG, part of Springer Nature 2018.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Up to 10% of all cancer patients develop metastatic disease in the bone. The purpose of the present report is to describe radiation therapy, including radionuclide treatment, conventional external beam radiation therapy (CEBRT), and stereotactic body radiation therapy (SBRT), for the management of spinal metastases. Radionuclide treatment can provide palliation in patients with painful skeletal metastases. CEBRT can be offered for palliation, treatment of cord compression, to prevent morbidity of bone metastases. Spinal SBRT can also be used for palliation or spinal cord compression and is typically recommended for us over CEBRT for radioresistant histologies.

AB - Up to 10% of all cancer patients develop metastatic disease in the bone. The purpose of the present report is to describe radiation therapy, including radionuclide treatment, conventional external beam radiation therapy (CEBRT), and stereotactic body radiation therapy (SBRT), for the management of spinal metastases. Radionuclide treatment can provide palliation in patients with painful skeletal metastases. CEBRT can be offered for palliation, treatment of cord compression, to prevent morbidity of bone metastases. Spinal SBRT can also be used for palliation or spinal cord compression and is typically recommended for us over CEBRT for radioresistant histologies.

KW - Biological effective dose

KW - Bone metastases

KW - External beam radiation therapy

KW - Radiation resistance

KW - Radionuclide treatment

KW - Stereotactic body radiation therapy

UR - https://www.scopus.com/pages/publications/105008838916

UR - https://www.scopus.com/inward/citedby.url?scp=105008838916&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-76252-4_20

DO - 10.1007/978-3-319-76252-4_20

M3 - Chapter

AN - SCOPUS:105008838916

SN - 9783319762517

SP - 245

EP - 254

BT - Metastatic Spine Disease

PB - Springer International Publishing

ER -

Radiation Therapy for Spinal Metastases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this